L Cell Urolithin A Review
L Cell is one of a growing number of longevity-focused brands offering urolithin A, the gut-derived compound that has moved from cell cultures into real human trials over the last few years. This review looks at what the evidence actually supports, what is still early, and how to judge any urolithin A product on the things that matter rather than the marketing.
Who L Cell is and what they sell
L Cell is a UK-based supplement brand positioned around healthy aging and cellular health. Its urolithin A line is sold as capsules, both directly and through third-party pharmacies and marketplaces such as Medino. Because product formulations and labels change over time, we deliberately do not quote a specific milligram dose or price here. Before buying, check the current label for the per-serving urolithin A amount, the number of capsules per bottle, and whether the material is a branded, characterized urolithin A or a generic extract. Those three details tell you far more than any headline claim.
To evaluate L Cell fairly, it helps to separate two questions. First: is urolithin A itself worth taking, based on the human evidence? Second: does this particular product deliver a studied dose in a form you will actually keep using? The first question is about the molecule; the second is about the brand.
What urolithin A is, in plain terms
Urolithin A is not something plants make and it is not something most foods contain directly. It is a postbiotic: your gut bacteria produce it from ellagitannins, the polyphenols found in pomegranate, walnuts, and some berries. The catch is that only some people carry the microbial machinery to make meaningful amounts, which is why two people eating the same pomegranate can end up with very different urolithin A levels. A supplement supplies the finished compound directly, bypassing that lottery. For a fuller primer, see our urolithin A guide and our overview of mitochondrial health.
Mechanistically, the most studied action of urolithin A is support for mitophagy, the housekeeping process by which cells identify worn-out mitochondria and recycle them so newer, more efficient ones can take over. Mitophagy tends to become less efficient with age, and the interest in urolithin A rests on the idea that supporting this cleanup may help cells maintain energy production. That is the mechanism; the next section is what has actually been measured in people.
The human evidence, from most to least established
Urolithin A has a genuinely better human track record than most longevity ingredients, though the field is still young. The first-in-human work was Andreux and colleagues (2019, Nature Metabolism), which found the compound was safe and well tolerated at single doses up to 1,000 mg per day and produced a measurable shift in mitochondrial gene-expression signatures in older, sedentary adults.
Two randomized trials then looked at muscle. Liu, D'Amico and colleagues (2022, JAMA Network Open) gave urolithin A to older adults over roughly four months and reported improvements in measures of muscle endurance. Singh and colleagues (2022, Cell Reports Medicine) studied middle-aged adults over four months with 500 mg and 1,000 mg arms, and reported benefits for muscle strength and aspects of exercise performance. More recently, an eight-week randomized trial in resistance-trained men (Journal of the International Society of Sports Nutrition, 2024) and a trial in distance runners (2025) extended this work into already-active populations, and a Nature Aging RCT in 2025 reported support for immune-cell mitochondrial health in midlife adults over about 28 days. You can read these in more depth on our clinical studies page.
It is worth being honest about scale. A 2024 systematic review in Ageing Research Reviews on targeting aging with urolithin A concluded that the human evidence is still emerging: sample sizes are modest, endpoints cluster around muscle and mitochondrial markers, and long-term outcome data do not yet exist. That is not a criticism of urolithin A so much as an accurate description of where the science sits. The muscle and mitochondrial signals are the strongest; broader anti-aging claims are not yet earned.
What is still preclinical
Much of the excitement around urolithin A comes from animal and cell work that has not yet been confirmed in people. The foundational study by Ryu and colleagues (2016, Nature Medicine) showed urolithin A induced mitophagy, extended lifespan in the worm C. elegans, and improved muscle function in rodents. D'Amico and colleagues (2022, Aging Cell) reported joint and cartilage benefits in osteoarthritis models. Areas such as skin, gut, brain, and heart remain in early or preclinical research and should be read as hypotheses being explored, not established human outcomes. Any brand, L Cell included, that leans heavily on these areas is describing potential rather than proof.
How to judge L Cell, and any urolithin A brand
Four criteria matter more than branding. Dose: the human trials used 500 to 1,000 mg per day, so confirm the label lands in that window rather than a token amount. Our dosage page covers this in detail. Ingredient identity: a characterized, third-party-tested urolithin A gives you confidence in what is actually in the capsule. Testing and transparency: look for third-party verification of identity and purity. Format and adherence: the best product is the one you take every day for months, because that is how it was studied. On these axes, L Cell is a reasonable option to evaluate; just confirm the current label rather than relying on category reputation.
Where SOMA HEALTH fits
In the interest of transparency, SOMA HEALTH is a competitor to L Cell: we make our own urolithin A product. We have tried to keep this review even-handed, and the criteria above apply to us exactly as they apply to L Cell. Our own approach is a 1,000 mg daily serving delivered as sugar-free gummies, third-party tested, designed for the kind of daily consistency the trials required. If you prefer capsules, L Cell may suit you; if a gummy makes daily use easier, that is where we focus. Compare the field yourself on our best urolithin A gummies roundup.
Frequently asked questions
Is L Cell urolithin A a good product?
It is a legitimate option to consider. Whether it is right for you depends on the current per-serving dose, third-party testing, and whether a capsule fits your routine. Confirm those on the label, since formulations change.
How much urolithin A should a product contain?
Human trials used 500 to 1,000 mg per day, with 1,000 mg at the top of the studied range. A product delivering a fraction of that has less evidence behind its serving size.
Does urolithin A actually have human evidence?
Yes, more than most longevity ingredients. Randomized trials support muscle endurance, strength, and mitochondrial markers. Broader claims around skin, brain, gut, and heart remain preclinical.
How long until it might do something?
The muscle trials ran about four months of daily use. This is a consistency-over-months ingredient, not an overnight one. See how long urolithin A takes to work.
Capsules or gummies?
Both can deliver a studied dose. The deciding factor is which one you will take daily for months, since adherence drove the trial results.
How is SOMA HEALTH different from L Cell?
SOMA HEALTH is a competing brand offering a 1,000 mg daily serving as sugar-free, third-party-tested gummies rather than capsules. The same evaluation criteria apply to both.
See SOMA HEALTH Urolithin A Gummies
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.
A clinically studied 1,000 mg dose of Urolithin A in one simple daily gummy — to support mitophagy, muscle strength, and cellular energy.
Shop SOMA Urolithin A Gummies →